|
|
Volumn 42, Issue 5, 2007, Pages 669-674
|
|
Chemotherapy of leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives
a
a
|
|
Author keywords
Pyrone; Amastigotes; Antileishmanial activity; In vitro; Promastigote; Pyridinone
|
|
Indexed keywords
1 (2 METHOXY PHENYL) 2 METHYL 4 OXO 4H PYRAN 3 YLOXY)PENTYLOXY] 1H PYRIDIN 4 ONE;
1 (4 CHLORO PHENYL) 2 METHYL 3 [5 (2 METHYL 4 OXO 4H PYRAN 3 YLOXY)PENTYLOXY] 1H PYRIDIN 4 ONE;
1 (4 FLUORO PHENYL) 3 [5 (2 METHYL 4 OXO 4H PYRAN3YLOXY)PENTYLOXY] 1H PYRIDIN 4 ONE;
1 (BENZYL) 2 METHYL 3 [5 (2 METHYL 4 OXO 4H PYRAN 3 YLOXY)PENTYLOXY] 1H PYRIDIN 4 ONE;
1,5 BIS[(1 BENZYL) 2 METHYL 4 1H PYRIDONE 3 YLOXY]PENTANE;
1,5 BIS[1 (1 PHENYL) 2 METHYL 4 1H PYRIDONE 3 YLOXY]PENTANE;
1,5 BIS[1 (2,4 DIMETHYL PHENYL) 2 METHYL 4 1H PYRIDONE 3 YLOXY]PENTANE;
1,5 BIS[1 (2,6 DIMETHYL PHENYL) 2 METHYL 4 PYRIDONE 3 YLOXY]PENTANE;
1,5 BIS[1 (4 METHOXY PHENYL) 2 METHYL 4 1H PYRIDONE 3 YLOXY]PENTANE;
1,5 BIS[1 (CYCLOHEXANE) 2 METHYL 4H PYRIDONE 3 YLOXY]PENTANE;
AMPHOTERICIN B;
ANTILEISHMANIAL AGENT;
MILTEFOSINE;
PYRIDONE DERIVATIVE;
PYRONE DERIVATIVE;
UNCLASSIFIED DRUG;
AMASTIGOTE;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG STRUCTURE;
IN VITRO STUDY;
LEISHMANIASIS;
MOUSE;
NONHUMAN;
ANTIPROTOZOAL AGENTS;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
LEISHMANIASIS;
PYRIDONES;
|
|
EID: 34248151496
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2006.11.011 Document Type: Article |
|
Times cited : (11)
|
|
References (19)
|
